Faulty adrenaline-shot pens recalled by authorities

Defective pens could have serious consequences for users with allergies

The Danish Medicines Agency has recalled a batch of pens with adrenaline-shots, Berlingske Tidende reports.

The agency has been alerted that at least some of the batch of 500 are defective, so to be on the safe side, it has decided to recall the entire batch.

“People who have been prescribed these pens by their doctors have been given them because they are allergic to nuts or wasp stings, for example”, explained Doris Hovgaard, the agency’s medical chief.

Check your pen
The pen in question is the EpiPen 300 microgram dose. Anyone wishing to check whether their pen is potentially defective should look for product number 578818 and batch number 5FA665B. The expiry date of the pens in question is March this year.

If you find a potentially defective EpiPen, you should contact your local chemist and have it exchanged, the agency advises.


 





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.